New device could sharpen cataract surgery planning
NCT ID NCT06987474
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is testing a new device called Unity DX that measures the eye's shape and focus. The goal is to collect data to help plan cataract surgeries more accurately. About 400 people having cataract treatment will participate. This is a data-gathering study, not a treatment itself.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 400 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Jul 2025
- Expected to finish
-
May 2027
An estimate. End dates often move.
- Lead sponsor
-
A company
The lead sponsor is a pharmaceutical, biotech, or medical-device company.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Subjects will be recruited from clinical sites located in India, Spain, and the Philippines.
- Ages
-
18 years and older
- Sex
-
Anyone
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Able to understand and sign an IRB/IEC approved consent form; * Willing and able to attend study visit(s) as required by the protocol; * Consenting age at the jurisdiction of study site; * Other group-specific, protocol required inclusion criteria may apply. Exclusion Criteria: * Women of child-bearing potential; * Unable to fixate due to nystagmus or other eye movement abnormality (e.g., significant strabismus); * Unclear optical media preventing data capture from all devices in the study; * Contraindicated for pupil dilation (e.g., narrow angles, allergies) per investigator's clinical judgment; * Any ocular disease and/or condition that, in the investigator's clinical judgment, may put the subject at significant risk, may compromise study results, or may interfere significantly with the subject's participation in the study; * Other group-specific, protocol required exclusion criteria may apply.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Cataract are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
4 sites in 3 countries. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Asian Eye Institute
RECRUITINGMakati City, 1200, Philippines
-
Clinica Novovision - Clinica Madrid
RECRUITINGMadrid, 28046, Spain
-
Clinica Rementeria
RECRUITINGMadrid, 28101, Spain
-
Narayana Nethralaya
NOT_YET_RECRUITINGBangalore, 560010, India
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A lens that could let cataract patients see near and far without glasses
- One operation for cataract and glaucoma? eye surgeons test a Two-in-One approach
- Eye drops may shield the cornea after cataract surgery
- A simple blood draw might reveal hidden eye lymphoma
- Can a new lens make glasses obsolete after cataract surgery?
- Can a new lens design sharpen vision after macular surgery?